Form 8-K - Current report:
SEC Accession No. 0001104659-24-127477
Filing Date
2024-12-11
Accepted
2024-12-11 08:29:12
Documents
29
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430703d1_8k.htm   iXBRL 8-K 38936
2 EXHIBIT 99.1 tm2430703d1_ex99-1.htm EX-99.1 30246
6 GRAPHIC tm2430703d1_ex99-1img001.jpg GRAPHIC 75110
7 GRAPHIC tm2430703d1_ex99-1img002.jpg GRAPHIC 250049
8 GRAPHIC tm2430703d1_ex99-1img003.jpg GRAPHIC 101778
9 GRAPHIC tm2430703d1_ex99-1img004.jpg GRAPHIC 95883
10 GRAPHIC tm2430703d1_ex99-1img005.jpg GRAPHIC 104110
11 GRAPHIC tm2430703d1_ex99-1img006.jpg GRAPHIC 162308
12 GRAPHIC tm2430703d1_ex99-1img007.jpg GRAPHIC 123050
13 GRAPHIC tm2430703d1_ex99-1img008.jpg GRAPHIC 169608
14 GRAPHIC tm2430703d1_ex99-1img009.jpg GRAPHIC 120872
15 GRAPHIC tm2430703d1_ex99-1img010.jpg GRAPHIC 133917
16 GRAPHIC tm2430703d1_ex99-1img011.jpg GRAPHIC 82456
17 GRAPHIC tm2430703d1_ex99-1img012.jpg GRAPHIC 96439
18 GRAPHIC tm2430703d1_ex99-1img013.jpg GRAPHIC 121988
19 GRAPHIC tm2430703d1_ex99-1img014.jpg GRAPHIC 142446
20 GRAPHIC tm2430703d1_ex99-1img015.jpg GRAPHIC 303250
  Complete submission text file 0001104659-24-127477.txt   3125313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rsls-20241211.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20241211_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20241211_pre.xml EX-101.PRE 22381
31 EXTRACTED XBRL INSTANCE DOCUMENT tm2430703d1_8k_htm.xml XML 3571
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 241540251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)